Aspirin Boosts Immune Response to Stop Cancer Spread

A new study in mice shows that COX-1 inhibitors, such as aspirin, block a platelet-mediated pathway that cancer cells use to evade immune detection and spread to other tissues. By reducing TXA2 production, aspirin enhances T-cell activity, leading to fewer metastases in the lungs and liver—a finding that could inform treatment.